Search
for
Sort by
Research 391–420 of 1000+
- PLASMA C19 STEROID SULPHATE LEVELS AND INDICES OF ANDROGEN BIOAVAILABILITY IN FEMALE PATTERN ANDROGENIC ALOPECIA
- A Review: Proteins Involved in the Major Symptoms of Polycystic Ovarian Syndrome
- Can plant‐derived phytochemicals provide symptom relief for hair loss? A critical review
- Intracrinology and Testosterone Pellet Therapy: An Enzyme-Aware, Symptom-Driven Approach to Hormone Optimization in Aging
- Polycystic Ovary Syndrome: Current Insights Into Etiology, Symptoms, And Treatment Options
- Polycystic ovary syndrome: Pathophysiology, Symptoms, Risk factors, and Pharmacological treatment
- Non polycystic ovary syndrome–related endocrine disorders associated with hirsutism
- Pathogenesis and causes of hirsutism
- Diagnosis and treatments of hirsutism: where are we?
- Adult polycystic ovary syndrome begins in childhood
- The Role of Oral Contraceptives in the Treatment of Hyperandrogenic Disorders
- Differential Expression of miR-93 and miR-21 in Granulosa Cells and Follicular Fluid of Polycystic Ovary Syndrome Associating with Different Phenotypes
- Hirsutism – From Diagnosis to Use of Antiandrogens
- Treatment guidelines in adult women
- Promotion of Hair Growth by<i>Rosmarinus officinalis</i>Leaf Extract
- Abiraterone and spironolactone in prostate cancer: a combination to avoid
- Biology of Hair Growth
- Green Tea Extract: A Novel Addition to the Antihirsutism Armamentarium?
- Predictors of Scalp Hair Thinning in Women with Polycystic Ovary Syndrome
- Developmental origin of polycystic ovary syndrome - a hypothesis
- ACOG Practice Bulletin No. 108: Polycystic Ovary Syndrome
- Hair Loss in Women
- Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria
- Acne-associated syndromes: models for better understanding of acne pathogenesis
- Hormonal therapy for acne: why not as first line therapy? facts and controversies
- Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome
- Surrogate end-points or primary outcomes in clinical trials in women with polycystic ovary syndrome?
- ANTIANDROGEN AND HORMONAL TREATMENT OF ACNE
- Prevalence of vitamin D deficiency in Slovak women with polycystic ovary syndrome and its relation to metabolic and reproductive abnormalities
- Congenital adrenal hyperplasia